XML 78 R27.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity-Based Compensation (Tables)
6 Months Ended
Jul. 01, 2011
Equity-Based Compensation [Abstract]  
Schedule Of Assumptions Used To Calculate Weighted Average Fair Value Of Stock Option Grants
     7/1/11     7/2/10  

Expected volatility

     46.4     42.0

Risk-free interest rate

     2.2     2.3

Expected term (in years)

     5.3        5.3   

Expected dividend yield

     1.5     1.0
Schedule Of Stock Option Activity
     Shares     Weighted
Average
Exercise
Price
     Weighted
Average
Remaining
Contractual
Term (in years)
     Aggregate
Intrinsic
Value

(in  millions)
 

Outstanding – beginning of year

     26,851,964      $ 11.18         

Granted

     2,073,278      $ 5.37         

Exercised

     (263,821   $ 1.80         

Forfeited/expired

     (2,703,169   $ 29.32         
  

 

 

         

Outstanding – end of period

     25,958,252      $ 8.92         4.0       $ 1.5   
  

 

 

         

Exercisable – end of period

     21,841,803      $ 9.46         3.0       $ 1.1   

Shares expected to vest

     25,635,340      $ 8.96         3.9       $ 1.5   
Schedule Of Cash-Settled Stock Appreciation Rights Activity
     Shares     Weighted
Average
Exercise
Price
 

Outstanding – beginning of year

     445,233      $ 7.73   

Granted

     41,700      $ 5.38   

Forfeited/expired

     (31,036   $ 7.76   
  

 

 

   

Outstanding – end of period

     455,897      $ 7.51   
  

 

 

   
Schedule Of Restricted Stock Unit Activity
     Shares     Weighted
Average
Grant Date
Fair Value
 

Non-vested – beginning of year

     5,372,417      $ 7.19   

Granted

     2,793,050      $ 5.37   

Vested

     (2,279,895   $ 6.80   

Forfeited

     (391,299   $ 6.38   
  

 

 

   

Non-vested – end of period

     5,494,273      $ 6.48   
  

 

 

   
Schedule Of Performance Stock Unit Activity
   Shares     Weighted
Average
Grant Date
Fair Value
 

Non-vested – beginning of year

     2,127,318      $ 5.86   

Granted 1

     1,824,569      $ 5.58   

Vested

     (798,241   $ 5.07   

Forfeited

     (525,762   $ 7.82   
  

 

 

   

Non-vested – end of period

     2,627,884      $ 5.51   
  

 

 

   

1 

This includes the additional 183,737 shares from the 2010 grant that were earned based on 2010 operating earnings and strategic goals.

Schedule Of Equity-Based Compensation Expense
     Second Quarter     Six Months  
     7/1/11     7/2/10     7/1/11     7/2/10  

Cost of revenue – products

   $ 0.5      $ 0.6      $ 1.0      $ 1.0   

Cost of revenue – services

     0.6        0.6        1.2        1.1   

Research and development

     3.1        2.4        5.6        4.2   

Sales and marketing

     1.3        1.3        2.6        2.5   

General and administrative

     2.5        2.5        5.2        4.4   
  

 

 

   

 

 

   

 

 

   

 

 

 

Equity-based compensation expense before income taxes

     8.0        7.4        15.6        13.2   

Income tax benefit

     (1.2     (2.5     (2.6     (4.3
  

 

 

   

 

 

   

 

 

   

 

 

 

Total equity-based compensation expense after income taxes

   $ 6.8      $ 4.9      $ 13.0      $ 8.9   
  

 

 

   

 

 

   

 

 

   

 

 

 
Schedule Of Total Equity-Based Compensation Expense By Type
     Second Quarter     Six Months  
     7/1/11     7/2/10     7/1/11     7/2/10  

Stock options

   $ 1.3      $ 1.4      $ 2.6      $ 2.7   

Cash-Settled SARs

     (0.1     (0.1     (0.2     0.1   

Restricted Stock

     5.4        4.0        9.8        7.5   

Performance stock units

     1.4        2.1        3.4        2.9   
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

   $ 8.0      $ 7.4      $ 15.6      $ 13.2